相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Icosapent Ethyl on Total Ischemic Events From REDUCE-IT
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Michael Szarek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
G. W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes
Alexander C. Fanaroff et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia
Paul S. Myles et al.
BMJ OPEN (2017)
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome The IMPROVE-IT Trial
Sabina A. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Gregory G. Schwartz et al.
AMERICAN HEART JOURNAL (2014)
Reduction in Overall Occurrences of Ischemic Events With Vorapaxar: Results From TRACER
Harvey D. White et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Cono A. Ariti et al.
AMERICAN HEART JOURNAL (2011)
Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of 'days alive and out of hospital' from epidemiological data
Cara A. Wasywich et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Total Cardiovascular Disease Burden: Comparing Intensive With Moderate Statin Therapy Insights From the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) Trial
Matti J. Tikkanen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events
Virginie Rondeau et al.
BIOSTATISTICS (2007)
Shared frailty models for recurrent events and a terminal event
L Liu et al.
BIOMETRICS (2004)
分享论文
